The emergence of the metabolic syndrome with menopause.
暂无分享,去创建一个
[1] E. Vittinghoff,et al. Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause. , 2000, JAMA.
[2] C. Gohlke-Bärwolf. Coronary artery disease – is menopause a risk factor? , 2000, Basic Research in Cardiology.
[3] J. Després,et al. Deterioration of the metabolic risk profile in women. Respective contributions of impaired glucose tolerance and visceral fat accumulation. , 2001, Diabetes care.
[4] G. Dagenais,et al. Associations of HDL2 and HDL3 subfractions with ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[5] M. Cushman,et al. Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal. , 2002, Fertility and sterility.
[6] J. Meigs. Epidemiology of the metabolic syndrome, 2002. , 2002, The American journal of managed care.
[7] C. Christiansen,et al. Influence of menopause on serum lipids and lipoproteins. , 1990, Maturitas.
[8] P. Ridker,et al. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. , 1998, Circulation.
[9] P. Wilson,et al. Effects of Age, Sex, and Menopausal Status on Plasma Lipoprotein(a) Levels The Framingham Offspring Study , 1993, Circulation.
[10] I. Godsland,et al. Influence of age and menopause on serum lipids and lipoproteins in healthy women. , 1993, Atherosclerosis.
[11] Bittner,et al. Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group. , 1997, JAMA.
[12] K. Hirschhorn. Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis. , 1989, American journal of human genetics.
[13] B. Nicklas,et al. Differences in adipose tissue metabolism between postmenopausal and perimenopausal women. , 2002, The Journal of clinical endocrinology and metabolism.
[14] W C Willett,et al. Low-density lipoprotein subclass patterns and risk of myocardial infarction. , 1988, JAMA.
[15] P. Wilson,et al. Low density lipoprotein particle size and coronary artery disease. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.
[16] E. Poehlman,et al. Changes in Energy Balance and Body Composition at Menopause: A Controlled Longitudinal Study , 1995, Annals of Internal Medicine.
[17] J. Vague,et al. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. , 1956, The American journal of clinical nutrition.
[18] H. Burger,et al. Longitudinal study of risk factors for coronary heart disease across the menopausal transition. , 2000, American journal of epidemiology.
[19] M. Garaulet,et al. Body fat distribution in pre-and post-menopausal women: metabolic and anthropometric variables. , 2002, The journal of nutrition, health & aging.
[20] E. Poehlman,et al. Effect of menopausal status on body composition and abdominal fat distribution , 2000, International Journal of Obesity.
[21] W. Kannel,et al. Regional obesity and risk of cardiovascular disease; the Framingham Study. , 1991, Journal of clinical epidemiology.
[22] R. Walker,et al. Plasma cholesterol esterification and transfer, the menopause, and hormone replacement therapy in women. , 1999, The Journal of clinical endocrinology and metabolism.
[23] R. Paoletti,et al. Lipoprotein(a) and Other Lipids after Oophorectomy and Estrogen Replacement Therapy , 1996, Obstetrics and gynecology.
[24] U. Stenman,et al. Variation of postheparin plasma hepatic lipase by menstrual cycle. , 1986, Metabolism: clinical and experimental.
[25] L. Sjöström,et al. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. , 1983, The Journal of clinical investigation.
[26] J. Selby,et al. Concordance for dyslipidemic hypertension in male twins. , 1991, JAMA.
[27] C. Björkelund,et al. Reproductive history in relation to relative weight and fat distribution. , 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.
[28] J. Manson,et al. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. , 2002, JAMA.
[29] W. Kannel,et al. Menopause and risk of cardiovascular disease: the Framingham study. , 1977, Annals of internal medicine.
[30] K. Matthews,et al. Lipoprotein subclasses and coronary artery calcium in postmenopausal women from the healthy women study. , 2002, The American journal of cardiology.
[31] P. Wilson,et al. Differences in low density lipoprotein subfractions and apolipoproteins in premenopausal and postmenopausal women. , 1988, The Journal of clinical endocrinology and metabolism.
[32] C. Bouchard,et al. Loss of abdominal fat and metabolic response to exercise training in obese women. , 1991, The American journal of physiology.
[33] Charles Kooperberg,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.
[34] E. Poehlman,et al. Menopause‐associated changes in plasma lipids, insulin‐like growth factor I and blood pressure: a longitudinal study , 1997, European journal of clinical investigation.
[35] R. Siervogel,et al. Aging, body composition, and lifestyle: the Fels Longitudinal Study. , 1999, The American journal of clinical nutrition.
[36] M. Zamboni,et al. Body fat distribution in pre- and post-menopausal women: metabolic and anthropometric variables and their inter-relationships. , 1992, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.
[37] U. Smith,et al. Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. , 1990, Metabolism: clinical and experimental.
[38] C. Lindoff,et al. Passage of the menopause is followed by haemostatic changes. , 1993, Maturitas.
[39] K. Pennert,et al. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. , 1984, British medical journal.
[40] A. Folsom,et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. , 1997, American journal of epidemiology.
[41] J. Després,et al. Abdominal obesity as important component of insulin-resistance syndrome. , 1993, Nutrition.
[42] D. Levy,et al. Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study. , 1995, Circulation.
[43] R. D'Agostino,et al. Clustering of metabolic factors and coronary heart disease. , 1999, Archives of internal medicine.
[44] H. Burger,et al. Hormonal changes in the menopause transition. , 2002, Recent progress in hormone research.
[45] M. J. Toth,et al. Effect of menopausal status on insulin-stimulated glucose disposal: comparison of middle-aged premenopausal and early postmenopausal women. , 2000, Diabetes care.
[46] I. Godsland,et al. The effects of the menopause on insulin sensitivity, secretion and elimination in non‐obese, healthy women , 1993, European journal of clinical investigation.
[47] S. Thompson,et al. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. , 1995, The New England journal of medicine.
[48] C. Bouchard,et al. Genetics and the metabolic syndrome. , 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.
[49] G. Reaven. Banting lecture 1988. Role of insulin resistance in human disease. , 1988, Diabetes.
[50] P. Ridker,et al. Endogenous tissue-type plasminogen activator and risk of myocardial infarction , 1993, The Lancet.
[51] K. Matthews,et al. Carotid atherosclerosis in premenopausal and postmenopausal women and its association with risk factors measured after menopause. , 1998, Stroke.
[52] Després Jp. Abdominal obesity as important component of insulin-resistance syndrome. , 1993, Nutrition.
[53] A. Tremblay,et al. Subcutaneous adipose tissue metabolism at menopause: importance of body fatness and regional fat distribution. , 2000, The Journal of clinical endocrinology and metabolism.
[54] J. Hokanson,et al. Changes in LDL density across the menopausal transition. , 2000, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.
[55] P. Björntorp,et al. Is abdominal body fat distribution a major explanation for the sex difference in the incidence of myocardial infarction? The study of men born in 1913 and the study of women, Göteborg, Sweden. , 1992, American journal of epidemiology.
[56] A. Hofman,et al. Increased risk of atherosclerosis in women after the menopause. , 1989, BMJ.
[57] P. Wilson,et al. Effects of gender and menopausal status on plasma lipoprotein subspecies and particle sizes. , 1996, Journal of lipid research.
[58] L. Speroff,et al. The heart and estrogen/progestin replacement study (HERS). , 1998, Maturitas.
[59] T. Buchanan,et al. Comparison of estimates of insulin sensitivity in pre- and postmenopausal women using the insulin tolerance test and the frequently sampled intravenous glucose tolerance test. , 1994, Journal of the Society for Gynecologic Investigation.
[60] J. Pfeilschifter,et al. Changes in proinflammatory cytokine activity after menopause. , 2002, Endocrine reviews.
[61] H. Burger,et al. Impaired fasting glycaemia in middle-aged women: a prospective study , 2001, International Journal of Obesity.
[62] M. J. Toth,et al. Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women. , 2001, Diabetes care.
[63] P. Allhoff,et al. The Framingham Offspring Study , 1991 .
[64] T. Buchanan,et al. Original ArticlesComparison of Estimates of Insulin Sensitivity in Pre- and Postmenopausal Women Using the Insulin Tolerance Test and the Frequently Sampled Intravenous Glucose Tolerance Test , 1994 .
[65] N. Siseles,et al. Higher values of hepatic lipase activity in postmenopause: relationship with atherogenic intermediate density and low density lipoproteins , 2001, Menopause.
[66] David M. Herrington,et al. Adherence to National Cholesterol Education Program Treatment Goals in Postmenopausal Women With Heart Disease: The Heart and Estrogen/Progestin Replacement Study (HERS) , 1997 .
[67] J. Hokanson,et al. Plasma Triglyceride Level is a Risk Factor for Cardiovascular Disease Independent of High-Density Lipoprotein Cholesterol Level: A Metaanalysis of Population-Based Prospective Studies , 1996, Journal of cardiovascular risk.
[68] K. Reynolds,et al. Epidemiology of the Metabolic Syndrome , 2005, The American journal of the medical sciences.
[69] J. Sorkin,et al. Comparison of VO2max and disease risk factors between perimenopausal and postmenopausal women , 2002, Menopause.
[70] M. Matsuda,et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. , 2002, Diabetes.
[71] A Tremblay,et al. Visceral Obesity in Men: Associations With Glucose Tolerance, Plasma Insulin, and Lipoprotein Levels , 1992, Diabetes.
[72] K. Heaton,et al. Coronary heart disease risk factors in relation to the menopause. , 1992, The Quarterly journal of medicine.
[73] G. Reaven. Role of Insulin Resistance in Human Disease , 1988, Diabetes.
[74] P. Wilson,et al. Risk factors that attenuate the female coronary disease advantage. , 1995, Archives of internal medicine.
[75] K. Matthews,et al. Menopause and risk factors for coronary heart disease. , 1990, The New England journal of medicine.
[76] W. Janowitz,et al. Differences in prevalence and extent of coronary artery calcium detected by ultrafast computed tomography in asymptomatic men and women. , 1993, The American journal of cardiology.
[77] Ronald M. Lauer,et al. National Cholesterol Education Program. Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction: executive summary. National Heart, Lung and Blood Institute, National Institutes of Health. , 1991, Archives of internal medicine.
[78] C. Haudenschild,et al. The role of hepatic lipase in lipoprotein metabolism and atherosclerosis. , 1999, Current opinion in lipidology.
[79] P. Amouyel,et al. Multiple coronary heart disease risk factors are associated with menopause and influenced by substitutive hormonal therapy in a cohort of French women. , 1995, Atherosclerosis.
[80] K. Matthews,et al. Changes in Cardiovascular Risk Factors During the Perimenopause and Postmenopause and Carotid Artery Atherosclerosis in Healthy Women , 2001, Stroke.
[81] H. Cohen,et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. , 1999, The American journal of medicine.
[82] S. Thompson,et al. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities. , 1996, Circulation.
[83] E. Poehlman. Menopause, energy expenditure, and body composition , 2005, Acta obstetricia et gynecologica Scandinavica.
[84] E. Poehlman,et al. Weight Loss Reduces C-Reactive Protein Levels in Obese Postmenopausal Women , 2002, Circulation.
[85] Jukka T Salonen,et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. , 2002, JAMA.
[86] O. Lindquist. Intraindividual changes of blood pressure, serum lipids, and body weight in relation to menstrual status: results from a prospective population study of women in Göteborg, Sweden. , 1982, Preventive medicine.
[87] Shankuan Zhu,et al. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. , 2003, Archives of internal medicine.
[88] S. Crawford,et al. A Longitudinal Study of Weight and the Menopause Transition: Results From the Massachusetts Women's Health Study , 2000, Menopause.
[89] J. Mckenney,et al. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.